Up up all _老虎社区_美港股上老虎

2021-12-09

Up up all the way

Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE<blockquote>FDA 批准 Xaciato 后 Dare Bioscience 股价上涨 >Dare</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":602119706,"tweetId":"602119706","gmtCreate":1638980146783,"gmtModify":1638980146783,"author":{"id":4087297988376160,"idStr":"4087297988376160","authorId":4087297988376160,"authorIdStr":"4087297988376160","name":"riserr","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>Up up all the way</p></body></html>","htmlText":"<html><head></head><body><p>Up up all the way</p></body></html>","text":"Up up all the way","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/602119706","repostId":1196789631,"repostType":2,"repost":{"id":"1196789631","kind":"news","pubTimestamp":1638919795,"share":"https://www.laohunote.com/m/news/1196789631?lang=zh_CN&edition=full","pubTime":"2021-12-08 07:29","market":"us","language":"en","title":"Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE<blockquote>FDA 批准 Xaciato 后 Dare Bioscience 股价上涨 &gt;Dare</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1196789631","media":"Marketwatch","summary":"Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and ","content":"<p>Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of age and older.</p><p><blockquote>在美国食品和药物管理局批准 Xaciato 治疗 12 岁及以上女性细菌性阴道病后，Dare Bioscience Inc. 的股价在周二盘后交易中上涨超过 35%。</blockquote></p><p> The approval marks the first FDA green light for the San Diego company, which said it is in talks on strategic partnering and other activities aimed at supporting a robust market introduction of the drug in the U.S. next year.</p><p><blockquote>该批准标志着 FDA 首次为这家圣地亚哥公司开绿灯，该公司表示正在就战略合作伙伴关系和其他活动进行谈判，旨在支持该药物明年在美国的强劲市场推广。</blockquote></p><p> Dare previously received FDA qualified-infectious-disease-product designation for Xaciato, which provides a five-year extension of the three years of market exclusivity available to the product.</p><p><blockquote>Dare 此前获得了 Xaciato 的 FDA 合格传染病产品名称，这使得该产品三年的市场独占权延长了五年。</blockquote></p><p> Dare shares, which closed Tuesday at $2.12, were recently changing hands at $2.87, up 35.3%, in after-hours trading.</p><p><blockquote>Dare 股票周二收于 2.12 美元，最近在盘后交易中易手至 2.87 美元，上涨 35.3%。</blockquote></p><p></p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE<blockquote>FDA 批准 Xaciato 后 Dare Bioscience 股价上涨 &gt;Dare</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDare Bioscience Shares Rally After FDA OKs Xaciato >DARE<blockquote>FDA 批准 Xaciato 后 Dare Bioscience 股价上涨 &gt;Dare</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Marketwatch</strong><span class=\"h-time small\">2021-12-08 07:29</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of age and older.</p><p><blockquote>在美国食品和药物管理局批准 Xaciato 治疗 12 岁及以上女性细菌性阴道病后，Dare Bioscience Inc. 的股价在周二盘后交易中上涨超过 35%。</blockquote></p><p> The approval marks the first FDA green light for the San Diego company, which said it is in talks on strategic partnering and other activities aimed at supporting a robust market introduction of the drug in the U.S. next year.</p><p><blockquote>该批准标志着 FDA 首次为这家圣地亚哥公司开绿灯，该公司表示正在就战略合作伙伴关系和其他活动进行谈判，旨在支持该药物明年在美国的强劲市场推广。</blockquote></p><p> Dare previously received FDA qualified-infectious-disease-product designation for Xaciato, which provides a five-year extension of the three years of market exclusivity available to the product.</p><p><blockquote>Dare 此前获得了 Xaciato 的 FDA 合格传染病产品名称，这使得该产品三年的市场独占权延长了五年。</blockquote></p><p> Dare shares, which closed Tuesday at $2.12, were recently changing hands at $2.87, up 35.3%, in after-hours trading.</p><p><blockquote>Dare 股票周二收于 2.12 美元，最近在盘后交易中易手至 2.87 美元，上涨 35.3%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/dare-bioscience-shares-rally-after-fda-oks-xaciato-dare-271638915493?mod=investing\">Marketwatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DARE":"Dare Bioscience"},"source_url":"https://www.marketwatch.com/story/dare-bioscience-shares-rally-after-fda-oks-xaciato-dare-271638915493?mod=investing","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1196789631","content_text":"Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of age and older.\nThe approval marks the first FDA green light for the San Diego company, which said it is in talks on strategic partnering and other activities aimed at supporting a robust market introduction of the drug in the U.S. next year.\nDare previously received FDA qualified-infectious-disease-product designation for Xaciato, which provides a five-year extension of the three years of market exclusivity available to the product.\nDare shares, which closed Tuesday at $2.12, were recently changing hands at $2.87, up 35.3%, in after-hours trading.","news_type":1,"symbols_score_info":{"DARE":0.9}},"isVote":1,"tweetType":1,"viewCount":2093,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":13,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/602119706"}